Latest issue of Clinical laboratory
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
20/20 GeneSystems launches accelerator facility for clinical lab tests
, /in E-News /by panglobal20/20 GeneSystems has launched its Clinical Lab Innovation Axcellerator (CLIAx), believed to be the first shared CLIA laboratory facility geared to helping diagnostic test innovators worldwide substantially reduce the time and cost of launching their tests in the U.S.
Pureos Bioventures expands team of venture partners
, /in E-News /by panglobalPureos Bioventures, a venture capital fund dedicated to support private biotech companies developing novel therapies, has appointed several venture partners to its team. The firsttime fund has US$205 million under management and has invested in 11 private biotech companies so far. In addition, Pureos is a partner at BaseLaunch, an incubator of biotech startups in […]
Researchers demonstrate unique example of a photothermal daisy-chained process
, /in E-News /by panglobalUniqsis reports how researchers at the School of Chemistry, University of Bristol (UK) have successfully prepared bicyclic lactams in high overall yield and excellent purity, under flow through conditions, using a photochemical [2+2] cycloaddition followed by a thermal electrocyclic cascade.
Avacta appoints new members to Scientific Advisory Board of Therapeutics Division
, /in E-News /by panglobalAvacta Group, a clinical stage biopharmaceutical company developing cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms, has made new appointments to its Scientific Advisory Board (SAB),reflecting the progress ofthe Therapeutics Division and Avacta’s transition to a clinical stage company.
Agilent and Visiopharm expand collaboration with worldwide distribution deal
, /in E-News /by panglobalAgilent Technologies has signed a worldwide distribution agreement with Visiopharm, enabling Agilent to co-market Visiopharm’s portfolio of CE-IVD marked artificial intelligence (AI)-driven precision pathology software in addition to Agilent’s portfolio of automated pathology staining solutions.
Porvair expands porous plastics manufacturing capacity due to high demand
, /in E-News /by panglobalPorvair Sciences has installed new automated precision die-cutting equipmentthat has enabled a five-fold increase in its production capacity for porous plastic components. This major investment by the company is in response to a significant rise in demand from customers for precision components made from its high performance Vyon porous plastics.
Insightful Science acquires FCS Express for its Cloud for Scientific Discovery
, /in E-News /by panglobalSan Diego, California-based Insightful Science, the software company enabling the Cloud for Scientific Discovery, has acquired De Novo Software,the maker of FCS Express. FCS Express is one of the fastest-growing flow cytometry data analysis solutions in the industry.
Evaluation of the Microlute® CP Reversed Phase Solid Phase Extraction 96 well-plate by HPLC-MS
, /in White Papers /by panglobalBACKGROUND Solid phase extraction (SPE) is a sample preparation method for the clean-up of samples before chromatographic analysis such as HPLC, and GC. SPE offers a number of advantages to the analyst, including less system downtime and troubleshooting, cleaner chromatograms with a reduction of contaminating compounds, and greater reproducible analyte recoveries. Traditionally, SPE methods use […]
Basic Metabolic Panel. STAT
, /in Advertenties /by panglobalINTRODUCING the GEM Premier ChemSTAT, a rapid Basic Metabolic Panel analyzer from Instrumentation Laboratory. Offering a customized menu for the emergency department, lab-quality Creatinine (Crea) results and advanced connectivity, this new solution ensures simplicity at the point of care or in the lab. Features Intelligent Quality Management (iQM) for quality-assured testing to support rapid triage […]
Researchers identify new drug class that could treat range of cancers with BRCA gene mutations
, /in E-News /by panglobalScientists have identified a new class of targeted cancer drugs that offer the potential to treat patients whose tumours have faulty copies of the BRCA cancer genes.